These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 32782035)

  • 1. Risk factors of severe cases with COVID-19: a meta-analysis.
    Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
    Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
    Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
    PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver damage at admission is an independent prognostic factor for COVID-19.
    Chen LY; Chu HK; Bai T; Tu SJ; Wei Y; Li ZL; Hu LL; Zhu R; Zhang L; Han CQ; Xiao L; He Q; Song J; Liu WH; Zhu QJ; Chen H; Yang L; Hou XH
    J Dig Dis; 2020 Sep; 21(9):512-518. PubMed ID: 32713118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of elevated inflammatory markers and severe COVID-19: A meta-analysis.
    Ji P; Zhu J; Zhong Z; Li H; Pang J; Li B; Zhang J
    Medicine (Baltimore); 2020 Nov; 99(47):e23315. PubMed ID: 33217868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
    Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
    Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
    [No Abstract]   [Full Text] [Related]  

  • 8. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
    Li J; He X; Yuan Yuan ; Zhang W; Li X; Zhang Y; Li S; Guan C; Gao Z; Dong G
    Am J Infect Control; 2021 Jan; 49(1):82-89. PubMed ID: 32540370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis.
    Soraya GV; Ulhaq ZS
    Med Clin (Barc); 2020 Aug; 155(4):143-151. PubMed ID: 32586670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory findings of COVID-19: a systematic review and meta-analysis.
    Zhang ZL; Hou YL; Li DT; Li FZ
    Scand J Clin Lab Invest; 2020 Oct; 80(6):441-447. PubMed ID: 32449374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
    Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
    Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.
    Huang I; Pranata R; Lim MA; Oehadian A; Alisjahbana B
    Ther Adv Respir Dis; 2020; 14():1753466620937175. PubMed ID: 32615866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India.
    Gupta N; Ish P; Kumar R; Dev N; Yadav SR; Malhotra N; Agrawal S; Gaind R; Sachdeva H; Covid Working Group OMOTSH
    Monaldi Arch Chest Dis; 2020 Nov; 90(4):. PubMed ID: 33169598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.
    Wang D; Li R; Wang J; Jiang Q; Gao C; Yang J; Ge L; Hu Q
    BMC Infect Dis; 2020 Jul; 20(1):519. PubMed ID: 32677918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
    Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study.
    Liu S; Luo H; Wang Y; Cuevas LE; Wang D; Ju S; Yang Y
    BMC Infect Dis; 2020 Aug; 20(1):584. PubMed ID: 32762665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.
    Wang F; Hou H; Wang T; Luo Y; Tang G; Wu S; Zhou H; Sun Z
    Travel Med Infect Dis; 2020; 36():101782. PubMed ID: 32526372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?
    Zhang J; Lu S; Wang X; Jia X; Li J; Lei H; Liu Z; Liao F; Ji M; Lv X; Kang J; Tian S; Ma J; Wu D; Gong Y; Xu Y; Dong W
    Heart; 2020 Aug; 106(15):1148-1153. PubMed ID: 32451362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.